Polymorphisms in CYP1A1 are
known to cause variation in activity of the enzymes and possibly
alter the metabolism of carcinogens and steroidal hormones.
Hence, CYP1A1 polymorphisms have been reported to be associated
with increased risk of several cancers including that of prostate
(Cosma et al., 1993; Murata et al., 1998).